September 30, 2014 6:00 PM ET


Company Overview of EDP Biotech Corporation

Company Overview

EDP Biotech Corporation, a medical device company, engages in the development and sale of immunodiagnostic tests for humans and animals. It identifies and purifies proteins in the early stages of biological changes for the production of in vitro diagnostic tests. The company was founded in 2005 and is based in Knoxville, Tennessee.

6701 Baum Drive

Suite 110

Knoxville, TN 37919

United States

Founded in 2005





Key Executives for EDP Biotech Corporation

Chief Executive Officer and Director
Age: 51
President and Chief Operations Officer
Age: 42
Chief Administrative Officer
Age: 55
Chief Scientific Officer
Age: 45
Compensation as of Fiscal Year 2014.

EDP Biotech Corporation Key Developments

EDP Biotech Corporation Announces Board Appointments

EDP Biotech Corporation announced that Dr. William (Bill) H. West and former Chairman, President and CEO of Regions Financial Corporation, Jackson (Jack) W. Moore will be joining the company’s esteemed board of directors. Dr. William (Bill) H. West is the Founder-Emeritus of the West Clinic in Memphis, Tenn. Dr. West is board certified in internal medicine and medical oncology, and has a career long interest in healthcare delivery systems. Jackson (Jack) W. Moore is a Director of Methodist LeBonheur Healthcare., and is also the retired Executive Chairman, President and CEO of Regions Financial Corporation. Mr. Moore currently serves as the Vice Chairman of the Board of Trustees at Vanderbilt University.

EDP Biotech Plans to Commercialize ColoMarker

EDP Biotech announced its plans to commercialize the product and bring the new technology to market. Unlike other diagnostic tests currently in development, the ColoMarker test detects a level of CA11-19 antigen, a specific protein molecule found in the bloodstream. While every human being produces this protein, elevated levels in the bloodstream suggest the presence of colon cancer. ColoMarker(TM) has proven to be effective in identifying elevated levels of a biomarker in the bloodstream in 95% of early stage colorectal cancers, when the disease is most treatable and survival rates are highest. To date, physicians have relied primarily on colonoscopies and fecal occult blood testing (FOBT) to identify potential cases of early stage colon cancer.

EDP Biotech Corporation Welcomes Donald Wheeler to Scientific Advisory Board

EDP Biotech has announced that world renowned quality control expert, Dr. Donald Wheeler, is joining the company's already-decorated scientific advisory board.

Similar Private Companies By Industry

Company Name Region
AMBA Biosciences, LLC United States
Molecular Diagnostics & Therapeutics Inc. United States
Amylin Pharmaceuticals, LLC United States
NeuroVir Inc. United States
Talon Therapeutics, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EDP Biotech Corporation, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at